CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
Disulfiramdrug
Likely dose
Disulfiram 500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01286259
NCT01286259N/ACompleted
CompareCT.gov

Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals

University of California, San Francisco·interventional·Posted Jan 31, 2011·Updated Jun 30, 2020

In Brief

A clinical study evaluating Disulfiram for HIV-1 Infection. Completed, enrolled 16 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine whether a two-week course of disulfiram will reduce the HIV-1 latent reservoir in patients on highly active antiretroviral therapy (HAART).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV-1 Infection
CountriesUnited States
CollaboratorsJohns Hopkins University

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 31, 2011
Enrollment StartJan 1, 2011
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 15.4 years ago

Interventions

Disulfiramdrug

Open label 500mg disulfiram per day by mouth for 14 days